Patent Yard Sign in
Expired Canadian patentCanada

Alkylthioalkyl-isoxanzoles and -isoxazolines

CA 1134837 A · Owner: Cdc Life Sciences Inc. · Inventors: Shaw, Chia-Cheng; Rastogi, Ram B.; Micetich, Ronald G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Abstract of the Disclosure Compounds of the formula 1, 1, in which the dotted line represents an optional double bond, R1 is lower alkyl, COOH, COO(lower alkyl), CONH2, CON(lower alkyl)2, CN, CH2OH CH2OSO2(lower alkyl), CH2O(lower alkyl) or, CH2S(lower alkyl), R2 is H, H2, or lower alkyl R3, is H or S(lower alkyl), R4 and R5 are the same or different and each is H, lower alkyl, S(lower alkyl) COOH, or COO(lower alkyl), and the sulfoxides and sulfones of the above compounds as well as their pharmaceutically acceptable salts. The compounds possess anti-inflammatory, analgesic, and anti-pyretic properties, and methods for their preparation and use are also disclosed.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted November 2, 1982. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 2, 1999.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 5, 1979
GrantedNovember 2, 1982
Term endedNovember 2, 1999
Patent numberCA 1134837 A
Classification (IPC)C07D261/02 +2 more

Timeline

Timeline From CIPO dates

1980198219841986198819901992199419961998Application filedOct 5, 1979Patent grantedNov 2, 1982Term endedNov 2, 1999

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.